It is no secret that Uzbekistan has established effective cooperation with many countries of the world in the development of the pharmaceutical industry, in particular, supplying our people with high-quality…
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…